Uber faces fresh competition as rival Bolt enters London market

Estonia-based transportation network company Bolt, formerly known as Taxify, recently launched in London, the biggest ride-hailing market in Europe. The company joins an expanding list of start-ups in an attempt to gain market share from Ub....

Medtronic initiates pivotal trial for MiniMed™ 780G AHCL system

The next-gen system is designed to automate correction boluses delivery when a user experiences, or is likely to experience, prolonged high glucose levels. Renowned medical device company, Medtronic plc has recently announced the enrollmen....

Goldfinch Bio instigates Phase 1 trial of GFB-887 for Kidney Disease

Goldfinch Bio, Inc., a biotechnology firm developing precision therapies for kidney disease patients, has reportedly started dosing in its Phase 1 clinical trial assessing GFB-887. The firm’s selective and sub-type specific small mole....

Amazon’s Prime delivery air drone to go operational in a few months

The e-commerce giant claims its drone’s safety features to be as robust and stable as a commercial aircraft. Global e-commerce giant, Amazon has recently unveiled the latest version of its Prime Air delivery drone, claiming that it a....

Minoryx Therapeutics begins its Leriglitazone phase-2 clinical trial

· A patient participating in the clinical trial has already been dosed with the company’s lead candidate, leriglitazone. · The patient was given the dose at Hospital La Paz in Madrid by a clinical team led by Dr. Franci....

Thermo Fisher, Newomics ink disease biomarker validation partnership

The companies will look to develop and optimize microflow LC-MS solutions which could advance the understanding and diagnosis of complex diseases Leading biotechnology company Thermo Fisher Scientific has recently confirmed it will collabo....

Kite unveils study results for KTE-X19 in acute lymphoblastic leukemia

The outcome of the Phase 1 ZUMA-3 study was presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting.   The results would be facilitating guidance on KTE-X19 safety & dosing management to help the ongoi....

Reata announces patient enrollment in clinal trial of Bardoxolone Methyl

Reata Pharmaceuticals, a clinical-stage biopharmaceutical company recently announced enrollment of first patient in the Phase 3 FALCON trial of bardoxolone in patients with ADPKD (autosomal dominant polycystic kidney disease), cites source.....

BioTheryX bags FDA approval for acute myeloid leukemia treatment drug

The company expects enrollment of Phase I Trial during the third quarter of 2019. U.S. biotechnology firm, BioTheryX, Inc. has recently announced that the the U.S. Food and Drug Administration (FDA) has approved its investigational ne....

NetApp, NVIDIA join forces to develop AI Centre of Excellence in India

It will help partners and customers who are looking for AI deployment as a part of their transformation journey NVIDIA, the graphics processing unit designer and NetApp, a data management service provider, have reportedly announced a partn....

Our Contributors

$row3->name
Mateen Dalal
$row3->name
Akshay Kedari
« First8384858687Last »